PT  - JOURNAL ARTICLE
AU  - Ana Andrade Oliveira
AU  - Joana Morais
AU  - Jorge Ribeiro
AU  - Paulo Ferreira Gouveia
TI  - Systemic infection following intravesical therapy with BCG
AID  - 10.1136/bcr-2021-243641
DP  - 2021 Nov 01
TA  - BMJ Case Reports
PG  - e243641
VI  - 14
IP  - 11
4099  - http://casereports.bmj.com/content/14/11/e243641.short
4100  - http://casereports.bmj.com/content/14/11/e243641.full
SO  - BMJ Case Reports2021 Nov 01; 14
AB  - Immunotherapy with BCG is an effective and widely used treatment for non-muscle-invasive bladder cancer. BCG sepsis is a rare but life-threatening and frequently not a straightforward complication of this treatment; in cases with a high index of suspicion, anti-bacillary treatment should not wait for laboratory confirmation and be instituted immediately. We report a severe case of BCG sepsis, in which timely diagnosis and initiation of antituberculosis agents enabled a full recovery.